Oh wow, I assumed the main source of problems for this business was because creating models based on sampling the works of others was ethically dubious leading to lawsuits and bans in several countries. But no. It’s their CEO’s business model not aligning with the board.
It actually seems to be the opposite - Altman focussing on commercialization, whereas the board wants to continue the non-commercial focus.
I really hope this is the case.
Oh wow, I assumed the main source of problems for this business was because creating models based on sampling the works of others was ethically dubious leading to lawsuits and bans in several countries. But no. It’s their CEO’s business model not aligning with the board.